ELIZABETH CARLISLE: Open Payments
NPI 1982319679 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 38 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $209 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 12 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $158 |
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
| PFIZER INC. | 3 | $52 |
| ABBVIE INC. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Antares Pharma, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $25 |
| Ardelyx, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
Products named: Auvelity, Kerendia, FARXIGA, ELIQUIS, TRINTELLIX, XYOSTED, Ozempic, IBSRELA.
Industry payments across LA — which companies pay providers there.
